Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BECTON DICKINSON & COBDX · Entity 2498 | Director | January 27, 2026 | January 29, 2026 |
| QUEST DIAGNOSTICS INCDGX · Entity 2118 | Director | May 20, 2026 | May 21, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BECTON DICKINSON & CO
Report date January 27, 2026 · Filed January 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 59,160 |
Reported balance
After 2026-01-27 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-01-27 · Grant · Acquired 1,098 · Balance 59,160 F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. F2: Includes units acquired through dividend investment since the last report filed by the reporting person. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 2,285 |
Reported balance
Holding disclosure · report date 2026-01-27 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 2,285 F2: Includes units acquired through dividend investment since the last report filed by the reporting person. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.
F2: Includes units acquired through dividend investment since the last report filed by the reporting person.
QUEST DIAGNOSTICS INC
Report date May 20, 2026 · Filed May 21, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 31,140 |
Reported balance
After 2026-05-20 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-05-20 · Grant · Acquired 1,142 · Balance 31,140 F1: Represents an award of restricted stock units. F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units.
F2: The amount includes shares acquired via dividend reinvestment since the date of reporting person's last filing on Form 4 pursuant to the Amended and Restated Deferred Compensation Plan for Directors.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
BARD C R INC /NJ/
Report date December 29, 2017 · Filed January 03, 2018
Section 16 reporting ended · disclosed 2018-01-03. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 73,030.022 |
Reported balance
After 2017-08-15 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2017-08-15 · Gift · Disposed 935 · Balance 73,030.022 |
| Common StockSEC Table I · non-derivative | Direct | 67,498.022 |
Reported balance
After 2017-10-30 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2017-10-30 · Gift · Disposed 5,532 · Balance 67,498.022 |
| Common StockSEC Table I · non-derivative | Direct | 128,617.022 |
Reported balance
After 2017-12-29 transaction · row 3
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 3 · 2017-12-29 · Grant · Acquired 61,119 · Balance 128,617.022 F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the December 29, 2017 transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger. F2: Includes 61,119 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. |
| Common StockSEC Table I · non-derivative | Direct | 153,451.022 |
Reported balance
After 2017-12-29 transaction · row 4
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 4 · 2017-12-29 · Grant · Acquired 24,834 · Balance 153,451.022 F3: Includes 24,834 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger. |
| Common StockSEC Table I · non-derivative | Direct | 153,451 |
Reported balance
After 2017-12-29 transaction · row 5
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 5 · 2017-12-29 · Disposition to issuer · Disposed 0.022 · Balance 153,451 F4: Includes 0.022 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration. |
| Common StockSEC Table I · non-derivative | Direct | 118,648 |
Reported balance
After 2017-12-29 transaction · row 6
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 6 · 2017-12-29 · Disposition to issuer · Disposed 34,803 · Balance 118,648 F5: Includes 34,803 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units. |
| Common StockSEC Table I · non-derivative | Direct | 61,119 |
Reported balance
After 2017-12-29 transaction · row 7
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 7 · 2017-12-29 · Disposition to issuer · Disposed 57,529 · Balance 61,119 F6: Includes 57,529 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit. |
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 8
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 8 · 2017-12-29 · Disposition to issuer · Disposed 61,119 · Balance 0 F2: Includes 61,119 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units. |
| Common StockSEC Table I · non-derivative | Indirect401(k) Plan | 0 |
Reported balance
After 2017-12-29 transaction · row 9
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 9 · 2017-12-29 · Disposition to issuer · Disposed 3,928.794 · Balance 0 F7: Includes 3,928.794 shares of Bard common stock held through the Bard 401(k) Plan that were disposed of upon the closing of the Merger. |
| Common StockSEC Table I · non-derivative | IndirectBy Children | 0 |
Reported balance
After 2017-12-29 transaction · row 10
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 10 · 2017-12-29 · Disposition to issuer · Disposed 802 · Balance 0 F8: Includes 802 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration. F9: The reporting person disclaims beneficial ownership of the shares held by his children and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $186.43 · Expires 2025-12-09 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-12-29 · Disposition to issuer · Disposed 65,857 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $168.87 · Expires 2024-12-10 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2017-12-29 · Disposition to issuer · Disposed 61,219 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $136.37 · Expires 2023-12-11 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2017-12-29 · Disposition to issuer · Disposed 65,385 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.69 · Expires 2022-12-12 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2017-12-29 · Disposition to issuer · Disposed 74,055 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $219.56 · Expires 2026-12-14 | Direct | 0 |
Reported balance
After 2017-12-29 transaction · row 15
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 15 · 2017-12-29 · Disposition to issuer · Disposed 50,929 · Balance 0 F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: This Form 4 is being filed in connection with the December 29, 2017 closing of the merger (the "Merger") of Lambda Corp. ("Lambda") with and into C. R. Bard, Inc. ("Bard") pursuant to the Agreement and Plan of Merger, dated as of April 23, 2017, among Bard, Becton, Dickinson and Company ("BD") and Lambda. Upon the closing of the Merger, each outstanding share of Bard common stock was converted into the right to receive $222.93 in cash (without interest) and 0.5077 of a share of BD common stock (the "Merger Consideration"). All of the December 29, 2017 transactions reported in this Form 4 occurred simultaneously upon the closing of the Merger.
F2: Includes 61,119 shares of Bard common stock deemed acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of Bard (as amended and restated) ("PLTIP"). In accordance with the Merger Agreement, these PLTIP units were cancelled in connection with the Merger and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent BD PLTIP units.
F3: Includes 24,834 Bard restricted stock units deemed acquired upon satisfaction of performance goals that were considered achieved upon the closing of the Merger.
F4: Includes 0.022 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.
F5: Includes 34,803 Bard restricted stock units that, upon the closing of the Merger, were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into equivalent adjusted BD restricted stock units.
F6: Includes 57,529 shares of restricted stock units acquired through deferral of compensation under Bard's Management Stock Purchase Program ("MSPP"). In accordance with the Merger Agreement (i) each Bard MSPP Unit that by its terms vested and/or became payable at the closing of the Merger was cancelled and converted into, with respect to each share of Bard common stock underlying such Bard MSPP Unit, the right to receive the Merger Consideration; and (ii) each Bard MSPP Unit that did not, by its terms, become payable at the closing of the Merger was assumed and converted in accordance with the exchange ratio set forth in the Merger Agreement into an equivalent adjusted BD MSPP Unit.
F7: Includes 3,928.794 shares of Bard common stock held through the Bard 401(k) Plan that were disposed of upon the closing of the Merger.
F8: Includes 802 shares of Bard common stock that, upon the closing of the Merger, were cancelled and converted into the right to receive the Merger Consideration.
F9: The reporting person disclaims beneficial ownership of the shares held by his children and this report should not be deemed an admission that the reporting person is the beneficial owner of his children's shares for purposes of Section 16 or for any other purpose.
F10: These stock options were assumed by BD and converted in accordance with the exchange ratio set forth in the Merger Agreement into stock appreciation rights with respect to BD common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 09, 2017 Filed Feb 10, 2017 18:23 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 20,324 | $239.56 | $4,868,880.44 |
DisclosureSEC source: 0001225208-17-002834 · doc4.xml · nonDerivative · entry 6 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,618.022 F5 · kind: Sales are pursuant to a previously disclosed 10b5-1 plan. F6 · price: Represents the weighted average sales price for price increments ranging from $239.45 to $239.83. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 18:23 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Tax withholdingCommon Stock | 18,461 | $236.68 | $4,369,349.48 |
DisclosureSEC source: 0001225208-17-002834 · doc4.xml · nonDerivative · entry 5 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,942.022 F4 · kind: Shares withheld to pay taxes upon vesting of performance-based restricted stock units granted under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 18:23 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantCommon Stock | 1,042 | $164.84 | $171,766.41 |
DisclosureSEC source: 0001225208-17-002834 · doc4.xml · nonDerivative · entry 4 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,403.022 F3 · kind: Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 18:23 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantCommon Stock | 2,430 | $235.49 | $572,240.70 |
DisclosureSEC source: 0001225208-17-002834 · doc4.xml · nonDerivative · entry 3 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143,361.022 F3 · kind: Restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 18:23 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantCommon Stock | 12,977 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-002834 · doc4.xml · nonDerivative · entry 2 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,931.022 F2 · price: Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated), 50% of which vest immediately and the remaining 50% vest in two equal annual installments on February 8, 2018 and February 8, 2019. Read SEC document |
| February 08, 2017 Filed Feb 10, 2017 18:23 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantCommon Stock | 32,297 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-002834 · doc4.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,954.022 F1 · price: Represents common shares acquired upon satisfaction of performance criteria underlying the award of restricted stock units under the 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 21:45 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 333 | $93.07 Strike: $0.00 | $30,992.31 |
DisclosureSEC source: 0001022079-17-000002 · wf-form4_148365273615937.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,877.674 Underlying: Common Stock · 333 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| December 14, 2016 Filed Dec 16, 2016 15:35 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GrantOption (Right to Buy) · Derivative | 50,929 | $0.00 Strike: $219.56 | $0.00 |
DisclosureSEC source: 0001225208-16-043390 · doc4.xml · derivative · entry 4 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,929 Underlying: Common Stock · 50,929 shares Expires 2026-12-14 F3 · security: Options granted under 2012 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F4 · derivative.exercise_date: Options vest in four equal annual installments beginning on December 14, 2017. Read SEC document |
| October 31, 2016 Filed Dec 16, 2016 15:35 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GiftCommon Stock | 373 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-043390 · doc4.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,657.022 Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:54 UTC | QUEST DIAGNOSTICS INC DGX · Entity 2118 | GrantPhantom Stock Units · Derivative | 367 | $83.69 Strike: $0.00 | $30,714.23 |
DisclosureSEC source: 0001022079-16-000324 · wf-form4_147570088229526.xml · derivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,522.994 Underlying: Common Stock · 367 shares Expires not disclosed F1 · derivative.exercise_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F1 · derivative.expiration_date: Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director. F2 · balance_after: Total number of phantom stock units accrued as of the transaction date in the reporting person's deferred compensation account includes phantom stock units credited as a result of dividend reinvestment transactions exempt from reporting pursuant to Rule 16a-11. Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 37,293 | $0.00 Strike: $84.58 | $0.00 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · derivative · entry 13 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 37,293 shares Expires 2021-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · security: Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F11 · derivative.exercise_date: Options fully vested and are currently exercisable. Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 22,322 | $226.97 | $5,066,419.88 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 8 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F6 · price: Represents the weighted average sales price for price increments ranging from $226.40 to $227.35. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 14,471 | $227.86 | $3,297,430.07 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 7 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 118,352.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F5 · price: Represents the weighted average sales price for price increments ranging from $227.42 to $228.39. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 500 | $228.58 | $114,290.35 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 6 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,823.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F4 · price: Represents the weighted average sales price for price increments ranging from $228.43 to $228.76. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 28, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 37,293 | $84.58 | $3,154,055.48 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 5 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,323.022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Read SEC document |
| September 27, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 49,846 | $0.00 Strike: $84.58 | $0.00 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · derivative · entry 12 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,293 Underlying: Common Stock · 49,846 shares Expires 2021-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · security: Options granted under 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F11 · derivative.exercise_date: Options fully vested and are currently exercisable. Read SEC document |
| September 27, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 5,154 | $0.00 Strike: $86.15 | $0.00 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · derivative · entry 11 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,154 shares Expires 2020-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F9 · derivative.exercise_date: Options fully vested in accordance with schedule upon achievement of certain performance criteria. Read SEC document |
| September 27, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 28,714 | $227.80 | $6,541,123.86 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 4 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F3 · price: Represents the weighted average sales price for price increments ranging from $227.22 to $228.21. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 27, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 26,286 | $228.49 | $6,005,975.11 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 3 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 124,744.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F2 · price: Represents the weighted average sales price for price increments ranging from $228.2200 to $228.9105. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 27, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 5,154 | $86.15 | $443,991.33 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 2 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,030.022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Read SEC document |
| September 27, 2016 Filed Sep 29, 2016 16:14 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 49,846 | $84.58 | $4,215,725.45 |
DisclosureSEC source: 0001225208-16-039751 · doc4.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,876.022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $86.15 | $0.00 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · derivative · entry 11 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,154 Underlying: Common Stock · 55,000 shares Expires 2020-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F9 · derivative.exercise_date: Options fully vested in accordance with schedule upon achievement of certain performance criteria. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 32,084 | $227.81 | $7,309,142.67 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · nonDerivative · entry 7 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F5 · price: Represents the weighted average sales price for price increments ranging from $227.02 to $228.01. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 22,916 | $228.24 | $5,230,327.22 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · nonDerivative · entry 6 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,114.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F4 · price: Represents the weighted average sales price for price increments ranging from $228.02 to $228.68. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 26, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 55,000 | $86.15 | $4,737,975.00 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · nonDerivative · entry 5 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,030.022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionOption (Right to Buy) · Derivative | 55,000 | $0.00 Strike: $86.15 | $0.00 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · derivative · entry 10 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,154 Underlying: Common Stock · 55,000 shares Expires 2020-12-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · security: Performance options granted under the 2003 Long Term Incentive Plan of C. R. Bard, Inc. (as Amended and Restated). F9 · derivative.exercise_date: Options fully vested in accordance with schedule upon achievement of certain performance criteria. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 36,035 | $230.26 | $8,297,505.58 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · nonDerivative · entry 4 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F3 · price: Represents the weighted average sales price for price increments ranging from $229.8400 to $230.6850. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | SaleCommon Stock | 18,965 | $229.27 | $4,348,118.83 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · nonDerivative · entry 3 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,065.022 F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. F2 · price: Represents the weighted average sales price for price increments ranging from $228.82 to $229.81. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4. Read SEC document |
| September 23, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | Exercise / conversionCommon Stock | 55,000 | $86.15 | $4,737,975.00 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · nonDerivative · entry 2 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,030.022 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Option exercise and sales are pursuant to a previously disclosed 10b5-1 plan. Read SEC document |
| July 29, 2016 Filed Sep 27, 2016 16:05 UTC | BARD C R INC /NJ/ BCR · Entity 170698 | GiftCommon Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-039708 · doc4.xml · nonDerivative · entry 1 RING TIMOTHY M · CIK 0001204666 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,030.022 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.